Effectiveness of a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal pneumonia in the elderly with chronic respiratory diseases: a case–control study of a single center

Effectiveness of a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal pneumonia in the elderly with chronic respiratory diseases: a case–control study of a single center

Abstract Background The effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in preventing pneumococcal pneumonia has been controversial. Methods To evaluate the effectiveness of the PPSV23 in elderly outpatients with chronic respiratory diseases, we carried out a case–control...

Full description

Bibliographic Details
Main Authors: Toshihiro Masuda, Eiji Nakatani, Toshihiro Shirai, Taisuke Akamatsu, Kanami Tamura, Shingo Takahashi, Yuko Tanaka, Hirofumi Watanabe, Yoshinari Endo, Takahito Suzuki, Mika Saigusa, Akito Yamamoto, Satoru Morita, Yoko Sato, Kazuhiro Asada
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Pulmonary Medicine
Subjects:
Chronic respiratory disease
Elderly
Pneumococcal polysaccharide vaccine
Pneumococcus
Pneumonia
Vaccine
Online Access:https://doi.org/10.1186/s12890-021-01491-w

Internet

https://doi.org/10.1186/s12890-021-01491-w

Similar Items